Conclusions
adenomyosis
ADENOMYOSIS, REMISSION
In this placebo-controlled randomized clinical trial of mifepristone vs placebo for the treatment of adenomyosis, 12 weeks of mifepristone treatment at a dose of 10 mg per day led to a significant remission for patient symptoms with acceptable tolerability. Therefore, mifepristone was effective and safe for the treatment of adenomyosis. However, further research is still needed to determine the long-term safety and efficacy.